Has Philip Dattilo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $732 in general payments to Philip Dattilo, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Philip Dattilo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Philip Dattilo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Philip Dattilo, MD

Interventional Cardiology · Fort Collins, CONPI 1245452994

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Medtronic at 45.0% of the total. Reporting peaked in 2019 at $340 and has fallen 95.8% since, to $14 in 2024. That places this record below the midpoint for interventional cardiology clinicians in CO, where the typical reported total is $6,820.

$732in general payments, 2019–2025

Across 8 payments — averaging $91.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$329
Abbott$156
Shockwave Medical, Inc$151
Asahi Intecc USA, Inc.$82
Atricure, Inc.$14

$109,192in research payments, 2019–2025

Across 56 payments — averaging $1949.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

CSL Behring$109K

What the payments were for

Food & beverage$732100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	2	$329
Abbott	3	$156
Shockwave Medical, Inc	1	$151
Asahi Intecc USA, Inc.	1	$82
Atricure, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$732 in reported general payments places this provider in the 10th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado →

Medicare billing

Part B allowed, 2024

$242,596

Medicare patients

1,595

Services billed

2,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	261	$343,685
Repatha SureclickEvolocumab	192	$220,827
JardianceEmpagliflozin	103	$123,198
Praluent PenAlirocumab	85	$92,456
XareltoRivaroxaban	46	$60,234
EntrestoSacubitril/Valsartan	19	$34,788
Repatha SyringeEvolocumab	13	$14,600
Ezetimibe	318	$8,117
Rosuvastatin Calcium	450	$7,022
Metoprolol Succinate	376	$5,021
Losartan Potassium	400	$3,585
Atorvastatin Calcium	303	$2,832
Valsartan	67	$2,729
PlavixClopidogrel Bisulfate	11	$2,645
ClopidogrelClopidogrel Bisulfate	175	$2,286

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Fort Collins

Justin StroteFort Collins$24K
John OldemeyerFort Collins$20K
Ehrin ArmstrongEnglewood$718K
Gareth MorganAurora$536K
Jamaluddin MolooAurora$272K
Jenny Zablah AlabiAurora$269K
Srinivas IyengarBoulder$254K
Nima AghiliLakewood$220K
Sridhar Sampath-KumarAurora$142K
Matthew ZipseAurora$137K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →